News
Martin Cannon, PhD | Meet a Scientist
Dr. Martin Cannon, of University of Arkansas for Medical Sciences (UAMS), is a 2021 recipient of OCRA’s Collaborative Research Development Grant. With his project, “Understanding and Targeting Myeloid Populations in … Continued
The Overview: May 2022
May has been officially recognized as National Cancer Research Month. Of course, at OCRA, every month is research month. Below, we highlight breakthroughs in our understanding and treatment of ovarian cancer, thanks … Continued
First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer
The following is a press release from Ovarian Cancer Research Alliance and Cancer Research Institute: NEW YORK, May 11, 2022 — The Cancer Research Institute (CRI) and Ovarian Cancer Research … Continued
Watch Now: What’s New in Ovarian Cancer Research and Treatment
Many exciting updates about progress against ovarian cancer were presented at this year’s Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer — the largest meeting of gynecologic cancer experts … Continued
New Ways to Build Community and Broaden Your Support System this Summer
As the busy summer months approach, OCRA remains committed to expanding support and offering new opportunities for our community to engage with others impacted by ovarian or other gynecologic cancers. … Continued
Urgent: Tell Your Senators to Increase Ovarian Cancer Research Funding
Urge your Senators TODAY to co-sponsor a $50 million budget — a $5 million funding increase over current levels — for the federal Ovarian Cancer Research Program! This April, we … Continued
Making a Difference in the Name of Mom
Mother’s Day signifies so much to so many—celebration, gratitude, and yes, remembrance or loss. This year, we want to acknowledge just some of our many supporters who have taken their … Continued
OCRA-Funded Study Pinpoints Partner Proteins That May Contribute to Ovarian Cancer Tumor Growth
The interaction between two partner proteins may promote the growth of the most common ovarian cancer subtype, according to recent findings from OCRA-funded researchers at University of Pennsylvania and Cedars-Sinai … Continued
New Immunotherapy Combination May Help Combat Ovarian Tumors
A therapeutic strategy that targets key tumor proteins shows promise for treating the most common subtype of ovarian cancer, according to a recent study led by OCRA grantee Duygu Ozmadenci, PhD, … Continued
OCRA in Conversation: Dr. Richard Pazdur, FDA
Audra Moran, President and CEO of OCRA, and Dr. Richard Pazdur, Head of the Oncology Center of Excellence at FDA, shared reflections — both personal and professional — about ovarian cancer … Continued
Benoît Bragantini, PhD | Meet a Scientist
Dr. Benoît Brangantini, of Mayo Clinic, is a 2021 recipient of OCRA’s Mentored Investigator Grant. With his project, “Probing Homologous Recombination DNA Repair Factors in Chromatin by cryo-EM,” Dr. Bragantini … Continued